SynapCell
banner
synapcell.bsky.social
SynapCell
@synapcell.bsky.social
SynapCell is an innovative CRO specializing in preclinical translational in vivo EEG for CNS drug discovery. We provide drug developers with decision-making capabilities to identify and test their most promising candidates.
SynapCell will be attending the AD/PD 2025 Conference on #Alzheimer’s & #Parkinson’s diseases! As a #CRO partner in #preclinicalEEG for #CNSDrugDiscovery, we’re eager to connect with researchers, biotech innovators, pharma experts to advance strategies for neurodegenerative diseases. Let's connect!
March 17, 2025 at 4:15 PM
March is Essential Tremor Month !
#Essentialtremor (ET) is one of the most common movement disorders, yet the impact of the disease on the patients’ quality of life remains underestimated and treatment options are limited.

#Neuroscience #EEG
March 6, 2025 at 4:05 PM
🎶Let’s talk Auditory Evoked Potentials (#AERP)

40Hz-Auditory Steady State Response (#ASSR) is a robust and translational auditory evoked potential that describes the resonance properties of stimulus-driven neural circuits.

🗨️ Contact us to learn more !

#neuroscience #EEG #schizophrenia #ASD
March 4, 2025 at 3:38 PM
Even if your drug effectively treats a CNS disorder, it may also influence sleep architecture—positively or negatively. Identifying these effects early is crucial, and preclinical studies can help forecast them!

Want to see how this works? 👉 Check out our poster synapcell.com/sleep-vigila...
February 28, 2025 at 3:45 PM
🌟 Accelerating Drug Discovery in CNS Disorders 🌟

Discover how SynapCell can revolutionize and accelerate your drug development process. Let's push the boundaries of neuroscience together!

#DrugDiscovery #CNSdisorders #PreclinicalResearch
February 25, 2025 at 3:16 PM
📅 Meet SynapCell at the upcoming #Neuroscience & #Epilepsy events in 2025! 💡If you’re working on #preclinical #CNS #DrugDiscovery and development, and looking for data-driven insights to guide your study with confidence, contact us or let’s connect at one of these events.

#PreclinicalResearch
February 20, 2025 at 3:49 PM
⚡Epilepsy is a complex spectrum of disorders requiring a tailored #DrugDiscovery approach.

Choosing the right model for the right seizure type is key. SynapCell provides gold-standard #preclinical & #translational models to predict drug efficacy with advanced #EEG biomarkers. #EpilepsyResearch #CNS
February 18, 2025 at 8:51 AM
#CNS #DrugDiscovery: 𝗦𝗹𝗲𝗲𝗽-𝘄𝗮𝗸𝗲 𝗰𝗵𝗮𝗿𝗮𝗰𝘁𝗲𝗿𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘆 𝗽𝗿𝗼𝘃𝗶𝗱𝗲 𝗮𝗱𝗱𝗶𝘁𝗶𝗼𝗻𝗮𝗹 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝘁𝗼 𝗶𝗻𝗰𝗿𝗲𝗮𝘀𝗲 𝗘𝗘𝗚 𝘀𝗲𝗻𝘀𝗶𝘁𝗶𝘃𝗶𝘁𝘆 𝘁𝗼 𝗽𝗿𝗼𝗳𝗶𝗹𝗲 & 𝗮𝘀𝘀𝗲𝘀𝘀 𝘆𝗼𝘂𝗿 𝗰𝗮𝗻𝗱𝗶𝗱𝗮𝘁𝗲 𝗰𝗼𝗺𝗽𝗼𝘂𝗻𝗱. By combining #EEG and #EMG recordings, we objectively monitor Wakefulness, #REM & #NREM sleep states.

👉Download the poster: bit.ly/3WPXT5l
February 13, 2025 at 9:53 AM
📌Join us at the 8th Annual Neuroscience Innovation Forum and discover how SynapCell can help accelerate drug development & provide decision-making data with #translational & predictive #EEG #biomarkers & reference models of #CNS disorders.
👉 lnkd.in/e9je-M_p

#drugdiscovery
January 14, 2025 at 9:03 AM
We would like to thank all our customers and partners. Your support fuels our mission to drive excellence in the future of neuroscience and drug discovery. Many thanks for your confidence and support in making this possible. Our best wishes for 2025 and a Happy New Year!
January 7, 2025 at 10:43 AM